SPONSOR
Boryung Pharmaceutical Co., Ltd
Total Trials
6
Recruiting
6
Phases
Phase 1
Conditions studied: Chronic Kidney Disease 5DSecondary HyperparathyroidismBreast CancerPrimary HypercholesterolemiaMixed DyslipidemiaOvarian CancerDiabete MellitusMetastatic Colorectal Cancer
Boryung Pharmaceutical Co., Ltd is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Chronic Kidney Disease 5D, Secondary Hyperparathyroidism, Breast Cancer, Primary Hypercholesterolemia.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Boryung Pharmaceutical Co., Ltd
How many clinical trials has Boryung Pharmaceutical Co., Ltd sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Boryung Pharmaceutical Co., Ltd, of which 6 are actively recruiting participants. These trials cover conditions including Chronic Kidney Disease 5D, Secondary Hyperparathyroidism, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Boryung Pharmaceutical Co., Ltd research focus on?
Boryung Pharmaceutical Co., Ltd clinical trials span Chronic Kidney Disease 5D, Secondary Hyperparathyroidism, Breast Cancer, Primary Hypercholesterolemia, Mixed Dyslipidemia, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Boryung Pharmaceutical Co., Ltd clinical trial?
To participate in a Boryung Pharmaceutical Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Boryung Pharmaceutical Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Boryung Pharmaceutical Co., Ltd
NCT06126016
Recruiting
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Chronic Kidney Disease 5D
NCT06537752
Recruiting
A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients
Breast Cancer
NCT06314919
Recruiting
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Primary Hypercholesterolemia
NCT07069335 Phase 1
Recruiting
A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer
Ovarian Cancer
NCT07083401 Phase 1
Recruiting
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Diabete Mellitus
NCT07263178
Recruiting
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
Metastatic Colorectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology